↓ Skip to main content

Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled…

Overview of attention for article published in Clinical and Translational Allergy, February 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study
Published in
Clinical and Translational Allergy, February 2014
DOI 10.1186/2045-7022-4-7
Pubmed ID
Authors

Margitta Worm, Sabina Rak, Frédéric de Blay, Hans-Jorgen Malling, Michel Melac, Véronique Cadic, Robert K Zeldin

Abstract

Allergic rhinoconjunctivitis (ARC) due to birch pollen is a growing health concern in Europe. Here, we report the efficacy and safety of 300IR birch pollen sublingual solution administered discontinuously for 2 consecutive years to patients with birch-associated allergic rhinoconjunctivitis.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 27%
Student > Master 3 14%
Student > Doctoral Student 3 14%
Other 2 9%
Professor 2 9%
Other 5 23%
Unknown 1 5%
Readers by discipline Count As %
Medicine and Dentistry 13 59%
Biochemistry, Genetics and Molecular Biology 2 9%
Agricultural and Biological Sciences 1 5%
Nursing and Health Professions 1 5%
Immunology and Microbiology 1 5%
Other 2 9%
Unknown 2 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2014.
All research outputs
#7,691,441
of 14,622,892 outputs
Outputs from Clinical and Translational Allergy
#293
of 449 outputs
Outputs of similar age
#73,799
of 186,233 outputs
Outputs of similar age from Clinical and Translational Allergy
#1
of 22 outputs
Altmetric has tracked 14,622,892 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 449 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,233 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.